118 related articles for article (PubMed ID: 2874073)
1. beta-1-Glycoprotein determination in normal and disturbed pregnancy.
Sterzik K; Wenske C; Rossmanith W; Benz R
Int J Gynaecol Obstet; 1986 Feb; 24(1):65-8. PubMed ID: 2874073
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic value of maternal pregnancy-specific beta 1-glycoprotein in threatened abortion.
Karg NJ; Csaba IF; Than GN; Vereczkey G; Szalmásy M
Z Geburtshilfe Perinatol; 1981 Feb; 185(1):38-40. PubMed ID: 6972125
[TBL] [Abstract][Full Text] [Related]
3. Human placental lactogen, pregnancy-specific beta-1-glycoprotein and alpha-fetoprotein in serum in threatened abortion.
Hertz JB; Schultz-Larsen P
Int J Gynaecol Obstet; 1983 Apr; 21(2):111-7. PubMed ID: 6193015
[TBL] [Abstract][Full Text] [Related]
4. [SP1-glycoprotein and beta-HCG during the first trimester in physiological, ectopic and abortive pregnancies].
Fanizza G; Pizza M; Ranieri DM
Ann Ostet Ginecol Med Perinat; 1987; 108(2):77-82. PubMed ID: 3498424
[No Abstract] [Full Text] [Related]
5. [Study of serum SP1 levels in early normal and abnormal pregnancies].
Zhang WY
Zhonghua Fu Chan Ke Za Zhi; 1990 Mar; 25(2):95-7, 124-5. PubMed ID: 2364798
[TBL] [Abstract][Full Text] [Related]
6. [Pregnancy-specific beta-glycoprotein in the serum of women with a complicated early pregnancy].
Radikov N
Akush Ginekol (Sofiia); 1989; 28(4):6-10. PubMed ID: 2802099
[TBL] [Abstract][Full Text] [Related]
7. [Significance of SP1 beta-1-glycoprotein in threatened abortion].
Iannotti G; Paladini A; Iannantuoni NM; Campanile M
Minerva Ginecol; 1980 Dec; 32(12):1115-9. PubMed ID: 6974834
[No Abstract] [Full Text] [Related]
8. [Monitoring trophoblast-specific-beta-1-globulin (SP1) and alpha 2-glycoprotein (SP3) in women with risk pregnancies].
Mikulíková L; Cerný V; Bauer J; Fialová L; Malbohan J
Cesk Gynekol; 1985 Nov; 50(9):640-4. PubMed ID: 3878735
[No Abstract] [Full Text] [Related]
9. Radioimmunoassay of SP1 (pregnancy-specific beta1-glycoprotein) in maternal blood and in amniotic fluid normal and pathologic pregnancies.
Würz H; Geiger W; Künzig HJ; Jabs-Lehmann A; Bohn H; Lüben G
J Perinat Med; 1981; 9(2):67-78. PubMed ID: 6787188
[TBL] [Abstract][Full Text] [Related]
10. Circulating levels of pregnancy specific beta 1 glycoprotein in pregnancies complicated by diabetes mellitus.
Grudzinskas JG; Gordon YB; Humphreys JD; Brudenell M; Chard T
Br J Obstet Gynaecol; 1979 Dec; 86(12):978-80. PubMed ID: 393298
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound and circulating placental protein measurements in complications of early pregnancy.
Stabile I; Campbell S; Grudzinskas JG
Br J Obstet Gynaecol; 1989 Oct; 96(10):1182-91. PubMed ID: 2480155
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of biochemical tests in the assessment of fetal outcome in threatened abortion.
Salem HT; Ghaneimah SA; Shaaban MM; Chard T
Br J Obstet Gynaecol; 1984 Apr; 91(4):382-5. PubMed ID: 6608956
[TBL] [Abstract][Full Text] [Related]
13. [Serum level of pregnancy-specific beta 1-glycoprotein (SP1) in pregnant women (a preliminary report)].
Radikov N; Liutakova E
Akush Ginekol (Sofiia); 1985; 24(2):24-8. PubMed ID: 3925803
[No Abstract] [Full Text] [Related]
14. The ratio between molecular variants of pregnancy-specific beta 1 glycoprotein (SP1) in the peripheral and retroplacental circulation during later pregnancy.
Grudzinskas JG; Teisner B; Chard T
Placenta; 1980; 1(3):223-6. PubMed ID: 6160575
[TBL] [Abstract][Full Text] [Related]
15. Pregnancy-specific beta 1-glycoprotein as a prognostic indicator in complications of early pregnancy.
Ho PC; Jones WR
Am J Obstet Gynecol; 1980 Oct; 138(3):253-6. PubMed ID: 6968160
[TBL] [Abstract][Full Text] [Related]
16. Human chorionic gonadotrophin and pregnancy-specific beta-1-glycoprotein in predicting pregnancy outcome and in association with early pregnancy vomiting.
Kauppila A; Heikinheimo M; Lohela H; Ylikorkala O
Gynecol Obstet Invest; 1984; 18(1):49-53. PubMed ID: 6611286
[TBL] [Abstract][Full Text] [Related]
17. [Serum pregnancy specific beta 1-glycoprotein (SP1) levels determined by radioimmunoassay--serum SP1 levels in patients with malignancies (author's transl)].
Ito H; Kitagawa I; Kubo A; Hashimoto S
Radioisotopes; 1981 Apr; 30(4):222-5. PubMed ID: 6974878
[No Abstract] [Full Text] [Related]
18. Pregnancy-specific beta-glycoprotein (SP1) in normal pregnancy in Nigeria.
Onyemelukwe GC; Ekwempu CC; Alexander LC
Int J Gynaecol Obstet; 1985 Sep; 23(4):347-9. PubMed ID: 2866125
[TBL] [Abstract][Full Text] [Related]
19. Comparison of serum and urine hCG levels with SP1 and PAPP-A levels in patients with first-trimester vaginal bleeding.
Masson GM; Anthony F; Wilson MS; Lindsay K
Obstet Gynecol; 1983 Feb; 61(2):223-6. PubMed ID: 6185893
[TBL] [Abstract][Full Text] [Related]
20. Identification of high-risk pregnancy by the routine measurement of pregnancy-specific beta 1-glycoprotein.
Grudzinskas JG; Gordon YB; Menabawey M; Lee JN; Wadsworth J; Chard T
Am J Obstet Gynecol; 1983 Sep; 147(1):10-2. PubMed ID: 6604456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
